[국제]Pfizer’s “90% Vaccine Prevention Rate” … “Don’t Fight Over It” at Biden’s Welcome



[ad_1]

Pfizer’s “Corona 19 Vaccine Clinical Trials Exceed 90% Prevention Rate”
“The clinical results of phase 3 of 94 patients exceeded 90% of the prevention rate”
“Prophylactic effect 28 days after the first administration of the vaccine and 7 days after the second administration”

[앵커]

The American pharmaceutical company Pfizer has announced interim results that the COVID-19 vaccine has a prevention rate of more than 90%.

US President Donald Trump and President-elect Joe Biden sent a welcoming message, emphasizing that the battle against Corona 19 is not over.

This is reporter Kim Jong-gyun.

[기자]

Pfizer, a US pharmaceutical company, announced an interim result that the prevention rate of the COVID-19 vaccine being developed with German Bioentech is greater than 90%.

Pfizer said an analysis of 94 participants in a phase 3 clinical trial of COVID-19 vaccine development showed that the prevention rate exceeded 90%.

They also explained that the anti-corona effect 19 appeared 28 days after the first administration of the vaccine and 7 days after the second time it was received.

However, Pfizer added that there are approximately 44,000 participants scheduled for clinical trials and that the number of prevention rates may change as the trial progresses.

Pfizer is also currently securing 2 months of stability data.

Here, if the vaccine is determined to be safe, the position is to apply for emergency use approval with the US Food and Drug Administration (FDA) later this month.

US President Trump and President-elect Biden got the news.

President Trump posted a post on Twitter that said, “Vaccines are coming soon, 90% effective, great news.”

Biden-elect also issued a statement expressing their welcome and gratitude.

Still, Biden emphasized that the fight against COVID-19 is not over, saying there are months left before widespread vaccinations can be done.

YTN Kim Jong-gyun[[email protected]]it is.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
[ad_2]